The global point-of-care molecular diagnostics market is gaining importance as healthcare providers increasingly prioritize rapid, accurate testing near the patient. These diagnostic platforms help clinicians identify infections and other medical conditions without depending entirely on centralized laboratory facilities, supporting faster clinical decisions and timely patient management....
The global Oligonucleotide Synthesis Market is experiencing strong growth as oligonucleotides become increasingly important in therapeutics, molecular diagnostics, genomics research, and genetic engineering. The market was valued at USD 3.6 billion in 2025 and is projected to increase from USD 4.1 billion in 2026 to USD 10.9 billion by 2033, registering a CAGR of 14.9% during the forecast...
The global molecular diagnostics market is witnessing steady expansion as healthcare providers increasingly prioritize early disease detection, accurate diagnosis, and personalized treatment. The Molecular Diagnostics Market was valued at USD 18.8 billion in 2025 and is projected to increase from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033....
The companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...
The blood group typing market is becoming increasingly important as healthcare systems manage growing transfusion requirements associated with chronic diseases, surgery, trauma, pregnancy-related complications, and organ transplantation. Blood Group Typing Market provides the foundation for identifying donor and recipient compatibility and plays an essential role in transfusion...
The global Molecular Diagnostics Market is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a 4.1% CAGR. The market reached USD 18.8 billion in 2025, with North America accounting for the largest regional share at 44.1%.
The industry's growth reflects increasing demand for precise diagnostics, technological advancement,...
The global Molecular Diagnostics Market size was valued at USD 18.8 billion in 2025 and is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033. North America dominated the market with a 44.1% revenue share in 2025. The growth of the molecular diagnostics industry is driven by increasing...
The global Blood Group Typing Market was valued at USD 2.3 billion in 2025 and is projected to reach USD 5.6 billion by 2033, growing at a CAGR of 12.0% from 2026 to 2033. The market is expanding rapidly due to the increasing burden of chronic diseases, rising surgical procedures, organ transplantation, and growing awareness regarding transfusion safety. Blood...
Infectious Disease Testing Market
The Infectious Disease Testing Market is experiencing strong expansion driven by the rising global burden of infectious diseases, increasing demand for early diagnosis, and advancements in molecular diagnostic technologies. The market size was valued at USD 28 billion in 2025 and is projected to grow from USD 30 billion in 2026 to USD...
Global analytical reagents market was valued at USD 9.8 billion in 2025 and is projected to reach USD 14.5 billion by 2034, exhibiting a remarkable CAGR of 4.4% during the forecast period.
Analytical reagents, encompassing high‑purity chemicals, solvents, standards and assay kits, have transitioned from niche laboratory consumables to pivotal enablers of modern scientific discovery. Their...
Global molecular biology reagents market was valued at USD 13,500 million in 2025 and is projected to reach USD 23,800 million by 2034, exhibiting a remarkable CAGR of 6.5% during the forecast period.
Molecular biology reagents, encompassing enzymes, nucleic acid purification kits, PCR reagents, sequencing consumables and other essential tools, have transitioned from niche research...
Non-Invasive Testing Revolutionizes Disease Detection and Monitoring
The healthcare industry is experiencing a major shift toward minimally invasive diagnostic technologies that enable faster, safer, and more accurate disease detection. Among these innovations, liquid biopsy has emerged as a groundbreaking approach that is transforming cancer diagnostics, treatment selection, and disease...